
This study investigates the genetic variation at the LRP1 locus, particularly the causal variant rs11172113, associated with various vascular diseases. Using CRISPR-Cas9 genome editing in human induced pluripotent stem cells, the researchers explored the role of rs11172113 in regulating LRP1 expression via enhancer regions. They identified transcription factors MECP2 and SNAIL as repressors of LRP1 expression. Notably, LRP1 knockout in smooth muscle cells resulted in altered proliferation, migration, and extracellular matrix remodeling, implicating TGF-β signaling in vascular disease mechanisms linked to LRP1.
Like
Save
Share